Blueweave
Global Cancer Diagnostics Market Bwc19374

Global Cancer Diagnostics Market, By Type (Endometrial Cancer, Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Kidney Cancer, Leukemia, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma), By Application (Imaging, Tumor Biomarkers Tests, Biopsy, Immunohistochemistry, Liquid Biopsy, In Situ Hybridization), By End-User (Hospitals, Imaging Centers, Diagnostic Laboratories, Cancer Research Institutes. and Documentation System), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: November 2021
  • Report ID: BWC19374
  • Available Format: PDF
  • Page: 194

Report Overview

The growing prevalence of oncologic cases, continual technological breakthroughs in diagnostics, and increasing demand for reliable diagnostic tests are the primary factors driving the demand for screening devices and procedures all over the world.

Global Cancer Diagnostics Market- Industry Trends & Forecast Report 2027

The global cancer diagnostics market was worth USD 15.4 billion in 2020 and is further projected to reach USD 31.8 billion by the year 2027, growing at a CAGR of 11.0% during the forecast period. The growing prevalence of oncologic cases, continual technological breakthroughs in diagnostics, and increasing demand for reliable diagnostic tests are the primary factors driving the demand for screening devices and procedures all over the world. Growing awareness and effective government policies are two additional factors that are contributing to the growth of the global cancer diagnostics market.

Cancer Diagnostics Market

Source: BlueWeave Consulting

Global Cancer Diagnostics Market- Overview

Cancer is one of the most common causes of death worldwide, and its prevalence is increasing at an alarming rate. Cancer detection at a preliminary phase is crucial in reducing these deaths. The most common cancers that cause death are colon, stomach, liver, lungs, breast, etc. Certain cancers are curable if they are detected early. Thus, healthcare experts are concentrating on the improvement of viable treatment procedures. As a result, healthcare organizations and market players are extending routine checkups through various awareness programs.

Global Cancer Diagnostics Market Forecast and Trends

Growth Drivers

Growing Prevalence of Cancer Worldwide

The prevalence of cancer is increasing at a very alarming rate around the world. According to research, cancer is one of the top causes of death, claiming the lives of countless people worldwide. Cancer claimed the lives of almost 10 million people in 2020 alone. According to some estimates, 1 in every 5 persons develop cancer, with 1 in one in every eight males and one in every 11 women affected. According to a report released by the Indian Council of Medical Research in 2020, the number of cancer cases in India is expected to rise from 1.39 million in 2020 to more than 1.57 million by 2025,

Increasing Cancer Diagnostic Centers

The dependence of people on hospitals for the diagnosis of cancer is very high. Due to this, countries are focusing on establishing cancer diagnostics centers that can share the burden from the hospitals and also strengthen healthcare infrastructure in their countries. This is making cancer diagnosis more accessible to people, which is going to accelerate the cancer diagnostics market. Early diagnosis of cancer plays a crucial role in the treatment of cancer, due to which a high number of people are approaching these diagnostics centers, which will drive the market growth in the forecast period.

Restraints

Expanding Adoption of Refurbished Medical Equipment

Refurbished medical equipment is proving to be incredibly cost-effective for healthcare providers. The availability of refurbished cancer diagnostic equipment, on the other hand, is a major impediment to the growth of the global cancer diagnostics market. Healthcare facilities, especially in the developing countries that do not have high budgets, often opt for refurbished equipment as they are available at a much lower cost. As a result, the revenue of the market players is cutting down to a great extent.

Impact of COVID-19 on Global Cancer Diagnostics Market

The COVID-19 has had a very adverse effect on the global cancer diagnostics market. Because of the overwhelming number of COVID-19 patients, medical resources and healthcare facilities were mostly allocated to patients infected with COVID-19. Furthermore, there was a substantial risk of virus transmission in all of the healthcare facilities. Because of all of these factors, the demand for cancer diagnostics had suddenly declined. Furthermore, almost all the research institutes started focusing on the development of vaccine and treatment procedures for COVID-19, which further affected the global cancer diagnostics market. However, the market regained its momentum very soon. This is because the early diagnosis of cancer is very crucial for controlling the severity of the disease. Therefore, a cancer diagnosis could not be put on hold for a long time and the demand for cancer diagnosis equipment flourished again.

Global Cancer Diagnostics Market - By Type

Based on type, the global cancer diagnostics market is categorized into endometrial cancer, bladder cancer, breast cancer, colon and rectal cancer, kidney cancer, leukemia, pancreatic cancer, prostate cancer, thyroid cancer, liver-lung cancer, melanoma, Non-Hodgkin lymphoma. The breast cancer segment dominated the market and is also projected to surge with the highest CAGR during the forecast period. The technique called mammography used for the detection of breast cancer in women is in huge demand worldwide. With the development of this technique and the efficiency it offers, along with the rising awareness towards breast cancer, this segment is proliferating at a great pace.

Global Cancer Diagnostics Market - By Application

Based on application, the global cancer diagnostics market is segmented into imaging, tumor biomarkers tests, biopsy, immunohistochemistry, liquid biopsy, in situ hybridization. The imaging segment accounts for the largest market share as this application offers many solutions for quick and non-invasive diagnosis which is also painless. These imaging techniques, together with other laboratory and genetic studies, are increasingly being employed in cancer diagnosis to detect the type of cancer and the stage of development. Thus, it helps in evaluating the type of treatment to be given to the patients. Because of these factors, the imaging segment is expanding rapidly.

Global Cancer Diagnostics Market - Regional Insights

Geographically, the global cancer diagnostics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. North America dominates the market due to a variety of variables such as the proximity of various biotechnology centers, as well as the presence of medical device companies in the region, which is one of the primary causes driving the diagnostics sector in the region. The availability of precise and delicate cancer screening and diagnostics in the region would also boost the market growth. Similarly, many government authorities are sponsoring Cervical Cancer Early Detection Programs, which are aiding the growth of the cancer diagnostics market in North America. North America is predicted to maintain its lead during the forecast period, owing to factors such as increased funding for widespread acceptance of trendsetting innovations in the arena of a cancer diagnoses.

Regional Insights

Competitive Landscape

The leading market players in the global cancer diagnostics market are GE Healthcare, Hologic, Inc., Janssen Diagnostics, LLC, Myriad Genetics, Inc., Qiagen N.V., Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Inc., AB SCIEX, Agilent Technologies Inc., Abbott Laboratories, Becton, Dickinson, and Company (BD), Biocartis SA, Biocare Medical, LLC, bioMérieux SA, Bio-Rad Laboratories, Inc., Cancer Genetics, Inc., Danaher Corporation, and other prominent players.

The market has a high concentration of global players which dominates a high percentage of the market. The dominance of these players can be attributed to the extensive research and development they undertake, as well as the fact that they offer a highly advanced and diverse range of products. Furthermore, the adoption of competitive market strategies like partnerships, mergers, acquisitions, joint ventures is also very prominent in this market.

Recent Developments

  • In June 2021, Ibex Medical Analytics, an Israeli AI-powered cancer diagnostics company announced it has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA) for its Galen platform which offers cancer detection and grading in biopsies.
  • In June 2021, Cancer Diagnostics, Inc., a US-based provider of anatomic pathology products, announced its acquisition of Anatech Ltd. Anatech Ltd. is a leading developer, manufacturer, and retailer of fixatives, processing, and staining reagents.

Scope of the Report

Attributes

Details

Years Considered

Historical data – 2017-2020

Base Year – 2020

Forecast – 2021 – 2027

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa

Product Service/Segmentation

By Type, By Application, By End-User, By Region

Key Players

GE Healthcare, Hologic, Inc., Janssen Diagnostics, LLC, Myriad Genetics, Inc., Qiagen N.V., Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Inc., AB SCIEX, Agilent Technologies Inc., Abbott Laboratories, Becton, Dickinson, and Company (BD), Biocartis SA, Biocare Medical, LLC, bioMérieux SA, Bio-Rad Laboratories, Inc., Cancer Genetics, Inc., Danaher Corporation, and other prominent players.

 

By Type

  • Endometrial Cancer
  • Bladder Cancer
  • Breast Cancer
  • Colon and Rectal Cancer
  • Kidney Cancer
  • Leukemia
  • Pancreatic Cancer
  • Prostate Cancer
  • Thyroid Cancer
  • Liver-Lung Cancer
  • Melanoma
  • Non-Hodgkin Lymphoma

By Application

  • Imaging
  • Tumor Biomarkers Tests
  • Biopsy
  • Immunohistochemistry
  • Liquid Biopsy
  • In Situ Hybridization

By End-User

  • Hospitals
  • Imaging Centers
  • Diagnostic Laboratories
  • Cancer Research Institutes. and Documentation System

By Region

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Latin America (LATAM)
  • Middle-East & Africa (MEA)
  1.  Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Research Methodology
    1. Qualitative Research
      1. Primary and Secondary Sources
    2. Quantitative Research
      1. Primary and Secondary Sources
    3. Breakdown of Primary Research Respondents
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Industry Participants
    5. Key Questionnaire asked during Primary Interviews
    6. Key Primary Responses
    7. Market Size Estimation
    8. Assumption for the Study
    9. Market Breakdown & Data Triangulation
  3. Executive Summary
  4. Global Cancer Diagnostics Market – Industry Insights
    1. DROC Analysis
      1. Growth Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
    2. Recent Developments / Technical Landscape
    3. Regulatory Framework
    4. Porter’s Five Forces Analysis
    5. Value Chain Analysis
    6. Strategic Outlook
  5. Global Cancer Diagnostics Market Overview
    1. Market Estimates & Forecast by Value, 2017-2027
      1. By Value (USD Million)
      2. By Volume (Thousand Units)
    2. Market Share & Forecast
      1. By Type
        1. Endometrial Cancer
        2. Bladder Cancer
        3. Breast Cancer
        4. Colon and Rectal Cancer
        5. Kidney Cancer
        6. Leukemia
        7. Pancreatic Cancer
        8. Prostate Cancer
        9. Thyroid Cancer
        10. Liver-Lung Cancer
        11. Melanoma
        12. Non-Hodgkin Lymphoma
      2. By Application
        1. Imaging
        2. Tumor Biomarkers Tests
        3. Biopsy
        4. Immunohistochemistry
        5. Liquid Biopsy
        6. In Situ Hybridization
      3. By End-User
        1. Hospitals
        2. Imaging Centers
        3. Diagnostic Laboratories
        4. Cancer Research Institutes. and Documentation System
      4. By Region
        1. North America
        2. Europe
        3. Asia-Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle-East & Africa (MEA)
  6. North America Cancer Diagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2017-2027
    2. Market Share and Forecast
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. U.S.
        2. Canada
  7. Europe Cancer Diagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2017-2027
    2. Market Share and Forecast
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Netherlands
        8. Rest of Europe
  8. APAC Cancer Diagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2017-2027
    2. Market Share and Forecast
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Rest of APAC
  9. LATAM Cancer Diagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2017-2027
    2. Market Share and Forecast
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. Mexico
        2. Brazil
        3. Rest of LATAM
  10. MEA Cancer Diagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2017-2027
    2. Market Share and Forecast
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. Saudi Arabia
        2. UAE
        3. South Africa
        4. Rest of Europe
  11. Competitive Landscape
      1. List of Key Producers and Their Offerings
      2. Market Share / Ranking Analysis (2020)
      3. Competitive Benchmarking, By Operating Parameters
  12. COVID-19 Impact
    1. Future Impact
    2. Key Developments during COVID-19
    3. Impact on Market
      1. Different Scenario
      2. Impact on Companies
    4. Regional Impact
  13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
    1. GE Healthcare
    2. Hologic, Inc.
    3. Janssen Diagnostics, LLC
    4. Myriad Genetics, Inc.
    5. Qiagen N.V.
    6. Roche Diagnostics
    7. Siemens Healthineers
    8. Sysmex Corporation
    9. Thermo Fisher Scientific, Inc.
    10. AB SCIEX
    11. Agilent Technologies Inc.
    12. Abbott Laboratories
    13. Becton, Dickinson and Company (BD)
    14. Biocartis SA
    15. Biocare Medical, LLC
    16. bioMérieux SA
    17. Bio-Rad Laboratories, Inc.
    18. Cancer Genetics, Inc.
    19. Danaher Corporation
    20. Other Prominent Players
  14. Key Strategic Recommendations

 

 

* Financial information of non-listed Companies will be provided as per availability

 

**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.

 

 

List of Figures

 

 

Fig: Global Cancer Diagnostics Segmentation

 

Fig: Global Cancer Diagnostics Market Value Chain Analysis,

 

Fig: Company Market Share Analysis, 2020

 

Fig: Global Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Global Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: Global Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: Global Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Global Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: North America Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: North America Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: North America Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: North America Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: North America Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: Europe Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Europe Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: Europe Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: Europe Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Europe Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By Region, By Value, 2017-2027

 

 

List of Tables

 

 

Table: Global Cancer Diagnostics Market Size, By Type, By Value, 2017-2027

 

Table: Global Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: Global Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: Global Cancer Diagnostics Market Size, By Region, By Value (USD Million), 2017-2027

 

Table: North America Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: North America Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: North America Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: North America Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: Europe Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: Europe Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: Europe Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: Europe Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: Latin America Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: Latin America Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: Latin America Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: Latin America Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: Hologic, Inc. Financial Analysis

Table: Hologic, Inc. Business Overview

Table: GE Healthcare Financial Analysis

Table: GE Healthcare Business Overview

Table: Janssen Diagnostics LLC Financial Analysis

Table: Janssen Diagnostics LLC Business Overview

Table: Myriad Genetics, Inc. Limited Financial Analysis

Table: Myriad Genetics, Inc. Limited Business Overview

Table: Qiagen N.V. Financial Analysis

Table: Qiagen N.V. Business Overview

Table: Roche Diagnostics Financial Analysis

Table: Roche Diagnostics Business Overview

Table: Siemens Healthineers Financial Analysis

Table: Siemens Healthineers Business Overview

Table: Sysmex Corporation Financial Analysis

Table: Sysmex Corporation Business Overview

Table: Thermo Fisher Scientific, Inc. Financial Analysis

Table: Thermo Fisher Scientific, Inc. Business Overview

Table: AB SCIEX Financial Analysis

Table: AB SCIEX Business Overview

Table: Agilent Technologies Inc. Financial Analysis

Table: Agilent Technologies Inc. Business Overview

Table: Abbott Laboratories Corporation Financial Analysis

Table: Abbott Laboratories Corporation Business Overview

Table: Becton, Dickinson, and Company (BD) Financial Analysis

Table: Becton, Dickinson, and Company (BD) Business Overview

Table: Biocartis SA Financial Analysis

Table: Biocartis SA Business Overview

Table: Biocare Medical, LLC Financial Analysis

Table: Biocare Medical, LLC Business Overview

Table: bioMérieux SA Financial Analysis

Table: bioMérieux SA Business Overview

Table: Bio-Rad Laboratories, Inc. Financial Analysis

Table: Bio-Rad Laboratories, Inc. Business Overview

Table: Cancer Genetics, Inc. Financial Analysis

Table: Cancer Genetics, Inc. Business Overview

Table: Danaher Corporation Financial Analysis

Table: Danaher Corporation Business Overview

 

Market Segmentation

By Type

  • Endometrial Cancer
  • Bladder Cancer
  • Breast Cancer
  • Colon and Rectal Cancer
  • Kidney Cancer
  • Leukemia
  • Pancreatic Cancer
  • Prostate Cancer
  • Thyroid Cancer
  • Liver-Lung Cancer
  • Melanoma
  • Non-Hodgkin Lymphoma

By Application

  • Imaging
  • Tumor Biomarkers Tests
  • Biopsy
  • Immunohistochemistry
  • Liquid Biopsy
  • In Situ Hybridization

By End-User

  • Hospitals
  • Imaging Centers
  • Diagnostic Laboratories
  • Cancer Research Institutes. and Documentation System

By Region

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Latin America (LATAM)
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions:

Ans: The global cancer diagnostics market reached USD 15.4 billion in 2020.
Ans: The major factors driving the growth of the global cancer diagnostics market are growing prevalence of cancer worldwide and increasing number of cancer diagnostic centers.
Ans: The key players in the global cancer diagnostics market are: GE Healthcare, Hologic, Inc., Janssen Diagnostics, LLC, Myriad Genetics, Inc., Qiagen N.V., Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Inc., AB SCIEX, Agilent Technologies Inc., Abbott Laboratories, Becton, Dickinson, and Company (BD), Biocartis SA, Biocare Medical, LLC, bioMérieux SA, Bio-Rad Laboratories, Inc., Cancer Genetics, Inc., Danaher Corporation, and other prominent players.
Ans: The hospital segment accounted for the largest share in the global cancer diagnostics market.
Ans: North America has the largest share in the global cancer diagnostics market.